Literature DB >> 15546503

Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage.

Kiyotsugu Yoshida1, Yoshio Miki.   

Abstract

BRCA1 (BReast-CAncer susceptibility gene 1) and BRCA2 are tumor suppressor genes, the mutant phenotypes of which predispose to breast and ovarian cancers. Intensive research has shown that BRCA proteins are involved in a multitude of pivotal cellular processes. In particular, both genes contribute to DNA repair and transcriptional regulation in response to DNA damage. Recent studies suggest that BRCA proteins are required for maintenance of chromosomal stability, thereby protecting the genome from damage. New data also show that BRCAs transcriptionally regulate some genes involved in DNA repair, the cell cycle, and apoptosis. Many of these functions are mediated by a large number of cellular proteins that interact with BRCAs. The functions of BRCA proteins are also linked to distinct and specific phosphorylation events; however, the extent to which phosphorylation-activated molecular pathways contribute to tumor suppressor activity remains unclear. Finally, the reasons why mutations in BRCA genes lead to the development of breast and ovarian cancers are not clearly understood. Elucidation of the precise molecular functions of BRCAs is expected to improve our understanding of hereditary as well as sporadic mammary carcinogenesis.

Entities:  

Mesh:

Year:  2004        PMID: 15546503     DOI: 10.1111/j.1349-7006.2004.tb02195.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  202 in total

Review 1.  Impact of germline and somatic BRCA1/2 mutations: tumor spectrum and detection platforms.

Authors:  H Wu; X Wu; Z Liang
Journal:  Gene Ther       Date:  2017-08-03       Impact factor: 5.250

Review 2.  Epigenetic changes of DNA repair genes in cancer.

Authors:  Christoph Lahtz; Gerd P Pfeifer
Journal:  J Mol Cell Biol       Date:  2011-02       Impact factor: 6.216

3.  Skp2 overexpression is associated with loss of BRCA2 protein in human prostate cancer.

Authors:  Arnaldo A Arbini; Margherita Greco; Jorge L Yao; Patricia Bourne; Ersilia Marra; Jer-Tsong Hsieh; Paul A di Sant'agnese; Loredana Moro
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

4.  Quantitative proteomic identification of the BRCA1 ubiquitination substrates.

Authors:  Meihua Song; Kevin Hakala; Susan T Weintraub; Yuzuru Shiio
Journal:  J Proteome Res       Date:  2011-10-11       Impact factor: 4.466

5.  High efficiency of BRCA1 knockout using rAAV-mediated gene targeting: developing a pig model for breast cancer.

Authors:  Yonglun Luo; Juan Li; Ying Liu; Lin Lin; Yutao Du; Shengting Li; Huanming Yang; Gábor Vajta; Henrik Callesen; Lars Bolund; Charlotte Brandt Sørensen
Journal:  Transgenic Res       Date:  2010-12-22       Impact factor: 2.788

Review 6.  Recent advances in breast cancer genetics.

Authors:  Boris Pasche
Journal:  Cancer Treat Res       Date:  2008

Review 7.  Clinically Applicable Inhibitors Impacting Genome Stability.

Authors:  Anu Prakash; Juan F Garcia-Moreno; James A L Brown; Emer Bourke
Journal:  Molecules       Date:  2018-05-13       Impact factor: 4.411

8.  Tumor characteristics as an analytic tool for classifying genetic variants of uncertain clinical significance.

Authors:  Robert M W Hofstra; Amanda B Spurdle; Diana Eccles; William D Foulkes; Niels de Wind; Nicoline Hoogerbrugge; Frans B L Hogervorst
Journal:  Hum Mutat       Date:  2008-11       Impact factor: 4.878

9.  Relationship between nm23H1 genetic instability and clinical pathological characteristics in Chinese digestive system cancer patients.

Authors:  Yue-Qin Yang; Liang Wu; Jin-Xing Chen; Jian-Zhong Sun; Meng Li; Dong-Mei Li; Hai-Ying Lu; Zhi-Hong Su; Xin-Qiu Lin; Ji-Cheng Li
Journal:  World J Gastroenterol       Date:  2008-09-28       Impact factor: 5.742

10.  Altered gene expression in morphologically normal epithelial cells from heterozygous carriers of BRCA1 or BRCA2 mutations.

Authors:  Alfonso Bellacosa; Andrew K Godwin; Suraj Peri; Karthik Devarajan; Elena Caretti; Lisa Vanderveer; Betsy Bove; Carolyn Slater; Yan Zhou; Mary Daly; Sharon Howard; Kerry S Campbell; Emmanuelle Nicolas; Anthony T Yeung; Margie L Clapper; James A Crowell; Henry T Lynch; Eric Ross; Levy Kopelovich; Alfred G Knudson
Journal:  Cancer Prev Res (Phila)       Date:  2010-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.